EWSR1 and Ewing sarcoma: Previously, we reported OTUD7A as a vulnerability in Ewing sarcoma by deubiquitinating and stabilizing EWS-FLI1; we have successfully utilized the AtomNet model [37] to identify 7Ai as an OTUD7A catalytic inhibitor [35].